Study on the reactive crystallization of potassium clavulanate

Bao-shu Liu,Jing-kang Wang,Jun-bo Gong,Qiu-xiang Yin,Mei-jing Zhang
DOI: https://doi.org/10.3969/j.issn.1001-8689.2005.11.005
2005-01-01
Abstract:Potassium clavulanate was an important β-lactamase inhibitor. Factors influencing the potassium clavulanate crystallization, such as solvents, crystal seeds, stirring rate, reactant adding rate, pH and temperature, were investigated. Under optimized conditions, potassium clavulanate with rod-like crystal form with average particle size 48.86μm was obtained, and also of good dispersity and mobility. Product from the optimized process conformed to Ch P2000 and USP24 specific requirements.
What problem does this paper attempt to address?